Wexford Capital »

Apogee Therapeutics shares owned by Wexford Capital

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Wexford Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $230k 3.9k 58.74

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
At&t (T)
Coca-cola Femsa Sab De Cv Spons Ads Rep (KOF)
Kraneshares Trust Csi Chi Internet (KWEB)
Star Bulk Carriers Corp. Shs Par (SBLK)
Cenovus Energy (CVE)
Canadian Natural Resources (CNQ)
Veren Com New (VRN)
Energy Transfer Com Ut Ltd Ptn (ET)
Invesco Db Commdy Indx Trck Unit (DBC)
Ishares Tr Msci Acwi Etf (ACWI)
Enterprise Products Partners (EPD)
Kyndryl Hldgs Common Stock (KD)
Nephros (NEPH)
Greenfire Res Com Shs (GFR)

View all positions for Wexford Capital

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
BlackRock
Driehaus Capital Management
Fairmount Funds Management
Perceptive Advisors
Vanguard Group
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners
Franklin Resources
Geode Capital Management

View all funds holding Apogee Therapeutics